Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0L7AW
|
||||
Former ID |
DNC010426
|
||||
Drug Name |
Benzaldehyde O-4-(decyloxy)phenylcarbamoyl oxime
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [530604] | ||
Structure |
Download2D MOL |
||||
Formula |
C24H32N2O3
|
||||
Canonical SMILES |
CCCCCCCCCCOC1=CC=C(C=C1)NC(=O)ON=CC2=CC=CC=C2
|
||||
InChI |
1S/C24H32N2O3/c1-2-3-4-5-6-7-8-12-19-28-23-17-15-22(16-18-23)26-24(27)29-25-20-21-13-10-9-11-14-21/h9-11,13-18,20H,2-8,12,19H2,1H3,(H,26,27)/b25-20+
|
||||
InChIKey |
LFWYEOAFEYYRNZ-LKUDQCMESA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [530604] | |
BioCyc Pathway | Anandamide degradation | ||||
KEGG Pathway | Retrograde endocannabinoid signaling | ||||
PANTHER Pathway | Anandamide degradation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.